Clonal selection drives genetic divergence of metastatic medulloblastoma.
Clonal selection drives genetic divergence of metastatic medulloblastoma.
复制标题
克隆选择驱动转移性髓母细胞瘤的遗传差异。
DOI:
10.1038/nature10825
复制
发表时间:
2012-02-15
期刊:
影响因子:
64.8
通讯作者:
Taylor, Michael D.
中科院分区:
文献类型:
--
作者:
Wu, Xiaochong;Northcott, Paul A.;Dubuc, Adrian;Dupuy, Adam J.;Shih, David J. H.;Witt, Hendrik;Croul, Sidney;Bouffet, Eric;Fults, Daniel W.;Eberhart, Charles G.;Garzia, Livia;Van Meter, Timothy;Zagzag, David;Jabado, Nada;Schwartzentruber, Jeremy;Majewski, Jacek;Scheetz, Todd E.;Pfister, Stefan M.;Korshunov, Andrey;Li, Xiao-Nan;Scherer, Stephen W.;Cho, Yoon-Jae;Akagi, Keiko;MacDonald, Tobey J.;Koster, Jan;McCabe, Martin G.;Sarver, Aaron L.;Collins, V. Peter;Weiss, William A.;Largaespada, David A.;Collier, Lara S.;Taylor, Michael D.
Medulloblastoma, the most common malignant paediatric brain tumour, arises in the cerebellum and disseminates through the cerebrospinal fluid in the leptomeningeal space to coat the brain and spinal cord. Dissemination, a marker of poor prognosis, is found in up to 40% of children at diagnosis and in most children at the time of recurrence. Affected children therefore are treated with radiation to the entire developing brain and spinal cord, followed by high-dose chemotherapy, with the ensuing deleterious effects on the developing nervous system. The mechanisms of dissemination through the cerebrospinal fluid are poorly studied, and medulloblastoma metastases have been assumed to be biologically similar to the primary tumour,. Here we show that in both mouse and human medulloblastoma, the metastases from an individual are extremely similar to each other but are divergent from the matched primary tumour. Clonal genetic events in the metastases can be demonstrated in a restricted subclone of the primary tumour, suggesting that only rare cells within the primary tumour have the ability to metastasize. Failure to account for the bicompartmental nature of metastatic medulloblastoma could be a major barrier to the development of effective targeted therapies.
登录
查看更多内容
影响因子:
12.4
作者:
Geurts, AM;Yang, Y;Hackett, PB
通讯作者:
Hackett, PB
影响因子:
10.5
作者:
Swartling, Fredrik J.;Grimmer, Matthew R.;Chesler, Louis
通讯作者:
Chesler, Louis
影响因子:
30.8
作者:
MacDonald, TJ;Brown, KM;Stephan, DA
通讯作者:
Stephan, DA
影响因子:
--
作者:
Forbes, S A;Bhamra, G;Bamford, S;Dawson, E;Kok, C;Clements, J;Menzies, A;Teague, J W;Futreal, P A;Stratton, M R
通讯作者:
Stratton, M R
影响因子:
30.8
作者:
Ramaswamy, S;Ross, KN;Golub, TR
通讯作者:
Golub, TR